S08.10 · Consumer Goods & Brands
A fast-growing, highly fragmented supplements and nutrition category where influencer-driven brand trust is being replicated cheaply by AI.
Dietary supplements run roughly $200-230B globally in 2025-2026 (Towards FnB, Grand View Research), projected to reach $393.6B by 2033 (Grand View Research). The broader health, wellness and nutrition brand category overlaps materially with the functional foods and beverages already counted elsewhere in consumer goods, so no clean non-overlapping aggregate exists for the category as a whole — a genuine measurement limitation better stated plainly than papered over with an invented number. Growth of 7-8% CAGR is led by GLP-1-adjacent nutrition, personalized supplementation and sports nutrition, and the category's real currency is trust: these brands sell credibility as much as compounds.
Fragmentation runs deeper here than anywhere else in the sector. Herbalife, GNC, Nestlé Health Science and Bayer Consumer Health lead individual sub-segments, but the DTC- and influencer-driven brand proliferation beneath them is extreme — arguably the most fragmented long tail in consumer goods. Revenue concentrates in the US and Asia-Pacific; manufacturing concentrates among contract nutraceutical manufacturers in the US, India and China.
Ingredient and active-ingredient suppliers and contract manufacturers sit upstream; specialty and vitamin retail, pharmacy, DTC subscription and e-commerce sit downstream. Gross margins of 55-65% are among the higher end of consumer goods. Regulatory gating is light to moderate but varies sharply by claim type and geography — supplement claims face a materially different bar than drug claims, and where a brand positions against that bar is a business-model decision as much as a legal one. Demand is largely transactional today with a growing subscription and replenishment mix. Brand and formulation IP hold pricing power, but channel power is rising: Amazon Subscribe & Save is capturing more of the replenishment relationship — the annuity these brands would rather own themselves.
Packaged foods and beverages (functional formats), beauty (ingestible beauty) and pet care (supplement crossover) border the category. Buying GLP-1-adjacent or personalized-nutrition brands adds exposure to where the growth is running; consolidating legacy vitamin brands defends against commoditization at the bottom of the range.
Adoption is already underway, compressing clinical-claims research and personalized-formulation R&D cycles. The structural threat lands on the category's core asset: influencer-driven brand trust itself. AI-generated health content and personalized-dosing apps are letting new entrants match incumbent credibility signals cheaply, eroding a moat that used to require years of accumulated audience trust — and a trust signal that can be replicated cheaply is no longer a moat, it is a cost line. A related boundary is forming inside the category: AI-driven personalized dosing and subscription nutrition is separating into its own segment, distinct from static-formula supplement makers, with algorithmic personalization rather than brand heritage as the differentiator — the same pattern now visible in beauty.